razuprotafib

Small moleculeexperimental

Clinical trial activity

2 trials · 15 clinical orgs · 0 marketing orgs

Phase 1
0
Phase 2
2
Phase 3
0
Phase 4
0

Earliest trial started Jul 31, 2020 (NCT04488081)

Timeline

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

COC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](Cc1ccc(NS(=O)(=O)O)cc1)c1csc(-c2cccs2)n1
Mol. weight
586.72 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT04511650Phase 2Oct 21, 2020Aerpio Therapeutics
NCT04488081Phase 2Jul 31, 2020Columbia University, Emory University, QuantumLeap Healthcare Collaborative, Sanford Health, University of Alabama, Birmingham, University of California, San Diego, University of California, San Francisco, University of Colorado, Denver, University of Minnesota, University of Pennsylvania, University of Southern California, Wake Forest University, Yale University, Yeshiva University
Showing 2 of 2 trials
Page 1 / 1

Organizations

Research & Development (15)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
Aerpio TherapeuticsFor profit1112020
Columbia UniversityAcademic/Hospital1012020
Emory UniversityAcademic/Hospital1012020
QuantumLeap Healthcare CollaborativeAcademic/Hospital1112020
Sanford HealthAcademic/Hospital1012020
University of Alabama, BirminghamAcademic/Hospital1012020
University of California, San DiegoAcademic/Hospital1012020
University of California, San FranciscoAcademic/Hospital1012020
University of Colorado, DenverAcademic/Hospital1012020
University of MinnesotaAcademic/Hospital1012020
University of PennsylvaniaAcademic/Hospital1012020
University of Southern CaliforniaAcademic/Hospital1012020
Wake Forest UniversityAcademic/Hospital1012020
Yale UniversityAcademic/Hospital1012020
Yeshiva UniversityAcademic/Hospital1012020
15 organizations
Page 1 / 1